Cryptococcus laurentii fungaemia in a cervical cancer patient

Braz J Infect Dis. 2015 Nov-Dec;19(6):660-3. doi: 10.1016/j.bjid.2015.06.014. Epub 2015 Sep 9.

Abstract

Infections caused by emerging Cryptococcus non-neoformans species are being reported with increasingly frequency. Here, we present a case of fungaemia by Cryptococcus laurentii in a woman receiving aggressive immunosuppressive therapy for cervical neoplasia. Three venous blood samples were aseptically collected on consecutive days and C. laurentii was isolated and identified through phenotypic and molecular methods. After central venous catheter removal and appropriate antifungal therapy, the patient showed significant improvement and blood culture became negative. Thus, patients following immunosuppressive therapies and using invasive medical devices are at risk of C. laurentii blood infections.

Keywords: Cancer; Cryptococcus laurentii; Fungaemia.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cryptococcosis / diagnosis
  • Cryptococcosis / immunology
  • Cryptococcosis / microbiology*
  • Cryptococcus / genetics
  • Cryptococcus / isolation & purification
  • Female
  • Fungemia / diagnosis
  • Fungemia / immunology
  • Fungemia / microbiology*
  • Humans
  • Immunocompromised Host / immunology*
  • Uterine Cervical Dysplasia / complications*
  • Uterine Cervical Dysplasia / microbiology
  • Uterine Cervical Neoplasms / complications*
  • Uterine Cervical Neoplasms / microbiology